News Interim report for the first nine months of 2022 Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement Read moreUltimate Guide: Everything You Need to Know About Industry 4.0 Continue Reading Previous Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022Next APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Related Stories News FLYR Expands Two-Year Presence and Major Investment in Saudi Arabia with Regional Headquarters News OnStation and Trimble: Live Digital Stationing Meets Location Precision News Fireflies launches Live Assist and Desktop App to deliver real-time help in every meeting News Aurasell Ends Tool Sprawl With Rapid Growth of the First AI-Native GTM Platform News SkySafe Unveils Forensics as a Service, Completing the Industry’s First End-to-End Drone Detection and Airspace Intelligence Platform News isolved Elevates the Customer Experience Through Innovation, Connection and Care